Sopharma AD (The Company) notifies that the filed on March 29, 2018 in the Commercial Register invitation for convening the Regular General Meeting of Shareholders of Sopharma AD on 11 May was not announced in accordance with the requirement of Art. 223, para 5 of the Commercial Law and the GMS cannot be conducted on this date.

The Board of Directors will propose another date for the GMS and will take the appropriate actions to convene it in the shortest possible time.

Sopharma AD notifies that for March 2018 the Company recorded a decrease of sales revenues of 10% compared to the same month of 2017, including 1% increase of domestic sales and a decrease of 19% of export sales.

For the first three months of this year, revenues from sales of products decreased by 3% compared to the same period of 2017, including 0.5% increase of domestic sales and 6% decrease of export sales.

Forum Pharmacy 4.0 at first sight promises to be strictly profiled as it concerns one of the most regulated and conservative in a lot of aspects business spheres – pharmacy. At the same time it is amongst the sectors, which are in the basis of the welfare of each society.